XML 63 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplemental Financial Statement Information (Tables)
12 Months Ended
Dec. 31, 2023
Additional Financial Information Disclosure [Abstract]  
Schedule of cash and cash equivalents
Cash and cash equivalents at December 31, 2023 and January 1, 2023 were as follows:
Fiscal Year
(In millions)20232022
Cash$329.8 $164.9 
Other short-term investments414.1 419.1 
Total cash and cash equivalents$743.9 $584.0 
Schedule of other non-operating income (expense)
Other income (expense) for the fiscal years ended December 31, 2023, January 1, 2023, and January 2, 2022 was as follows:
Fiscal Year
(in millions)202320222021
Rent, royalty income and other income$2.6 $2.3 $1.1 
Gains from disposal of property, plant and equipment, net0.3 0.2 2.9 
Net equity income (loss) on joint ventures (See Note 7)(1.6)12.6 0.1 
Gain on sales of businesses, net (See Note 6) — 13.8 
Joint venture restructuring credit (charge) (See Note 7) 0.9 — 
Litigation settlement (See Note 21) (28.5) 
Other — 0.3 
Total other income (expense), net$1.3 $(12.5)$18.2